Showing results (1721-1730 of 25,889) with videos related to
Sort By:
Pageof 2,589
Anticancer Research|June 16, 1999
Antiproliferative and cytotoxic effects of N,N-diethylaminoethyl ethers of flavanone oximes: a comparison with anthracycline(s), anthraquinone and nitroxides actionD Metodiewa, A Koceva-Chyła, A Kochman, et al.Anticancer Research|June 16, 1999
5,6 Dihydro-5'-azacytidine (DHAC) restores androgen responsiveness in androgen-insensitive prostate cancer cellsE Izbicka, J R MacDonald, K Davidson, et al.Anticancer Research|June 16, 1999
Clinical analysis of the novel breast cancer serum assay BT1M M Whitehurst, P H Aldenderfer, S Yanovich, et al.Anticancer Research|June 12, 1999
5-Fluorouracil plus high dose levofolinic acid and oral hydroxyurea for the treatment of primary hepatocellular carcinomas: results of a phase II multicenter study of the Southern Italy Oncology Group (G.O.I.M.)V Gebbia, E Maiello, G Serravezza, et al.Anticancer Research|June 12, 1999
DNA aneuploidy by flow cytometry is an independent prognostic factor in squamous cell carcinoma of the oral cavityJ Hemmer, E Nagel, K KraftAnticancer Research|June 12, 1999
Antiblastic chemotherapy in the presence of abdominal aorta aneurysm (AAA): guidelinesS Lauro, G Lanzetta, E Bria, et al.Anticancer Research|June 12, 1999
The differential expression of proinflammatory cytokines IL-6, IL-8 and TNF-alpha in renal cell carcinomaB König, F Steinbach, B Janocha, et al.Anticancer Research|June 12, 1999
Preclinical studies combining bispecific antibodies with cytokine-stimulated effector cells for immunotherapy of renal cell carcinomaD Elsässer, H Stadick, S Stark, et al.Anticancer Research|June 12, 1999
Life quality of patients with metastatic renal cell carcinoma and chemo-immunotherapy--a pilot studyM J Kröger, T Menzel, J E Gschwend, et al.Pageof 2,589